newsfilter
← Latest News
PR Newswire·

Aspaveli® (pegcetacoplan) receives positive CHMP opinion for treatment of PNH

STOCKHOLM, Oct. 15, 2021 /PRNewswire/ -- Swedish Orphan Biovitrum AB (publ) (Sobi™) (STO:SOBI) and Apellis Pharmaceuticals, Inc. (NASDAQ:APLS) announce today that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agenc